AIM ImmunoTech's total assets for Q3 2024 were $13.59M, a decrease of -13.53% from the previous quarter. AIM total liabilities were $10.68M for the fiscal quarter, a 11.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.